Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis

NCT02919605 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Leishmaniases

Interventions

DRUG: Single dose of Pentamidine
DRUG: Two doses of Pentamidine
DRUG: Three doses of Pentamidine

Sponsor

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado